Introducing Our New Purchasing Consortium Supplier Evaluate
Today MassBio launched our new partnership with Evaluate Ltd. Evaluate joins the MassBio Purchasing Consortium as the Primary Supplier of Life Sciences Market Intelligence and will offer MassBio members significant savings on their EvaluatePharma® service.
MassBio relies on EvaluatePharma for critical insights to analyze the life sciences industry landscape, trends and deals so we’re thrilled to be able to offer this important resource to MassBio members at a discount!
Evaluate will offer MassBio member substantial savings on EvaluatePharma subscriptions including access to their award-winning EP Vantage news and email alerts, exclusive industry reports, Quick Start needs analysis and EvaluatePharma training.
EvaluatePharma® can be used to…
- Develop compelling business cases and optimize product/company positioning
- Conduct market and competitive analysis of R&D and commercial landscape for strategic planning and critical business decisions
- Identify the best growth, investment opportunities and partners
- Benchmark deals to support negotiations and transactions: M&A, Licensing, Investments
- Conduct valuations of assets and companies
- Prepare presentations for investors, shareholders, industry events using highly reputable data
- Triangulate forecasts and other internal evaluations and analysis
- Identify lucrative global markets for your products
- Understand the dynamics behind USA product sales including drug price and annual cost per patient
- And more!
See contract details on our website here: www.massbio.org.
Welcome to the Purchasing Consortium, Evaluate!
Posted on July 30, 2014, in MassBio, Purchasing Suppliers and tagged Biotech, Evaluate, EvaluatePharma, Life Sciences, Life Sciences Market Intelligence, MassBio Purchasing Consortium, Primary Suppliers. Bookmark the permalink. Leave a comment.